Body weight changes what a testosterone test measures, and it changes the clinical meaning of the number on the report. Men carrying excess weight tend to show lower total testosterone on blood work, but the reason isn't always a hormonal deficiency. In many cases, the real driver is a drop in sex hormone-binding globulin (SHBG), the protein that carries testosterone in the blood. When SHBG falls, total testosterone falls with it, even when the body's actual supply of usable (free) testosterone remains within the reference range. That distinction matters for every man reviewing his lab results and deciding what to do next.
A 2025 clinical approach paper in the Journal of Clinical Endocrinology and Metabolism describes this pattern as "pseudo-hypogonadism of obesity," a state where low total testosterone reflects altered binding proteins rather than a problem with the testes or pituitary gland (Muir et al., 2025). Recognizing the difference between this pattern and true pathological hypogonadism shapes which tests to order, what follow-up looks like, and whether the cause is reversible.
Why Does Body Weight Lower Testosterone on Lab Work?
Fat tissue contains aromatase, an enzyme that converts testosterone into estrogen. The more fat a man carries, the more conversion takes place, shifting the testosterone-to-estrogen ratio. Excess weight also drives insulin resistance, which suppresses gonadotropin signaling from the pituitary gland and further reduces testosterone output.
A primary contributor to low readings on a standard body weight testosterone test is the drop in SHBG. Other mechanisms, including aromatase conversion and HPG axis suppression, also play a role.
The Role of SHBG
SHBG binds a large share of circulating testosterone and limits its availability to tissues. When body weight climbs, the liver produces less SHBG, and total testosterone on lab work drops in proportion. A 2024 prospective study tracking 61 adults with obesity over 3 years found that for every 1 kg of weight lost, total testosterone rose by 0.6% in male participants, and SHBG rose alongside it (Brzozowska et al., 2024). The relationship was consistent across dietary and surgical weight loss groups.
This is why a total and free testosterone panel drawn at a higher body weight often shows a total value well below the reference range while calculated or dialysis-measured free testosterone sits closer to normal. A single total testosterone reading in this scenario can be misleading.
Pseudo-hypogonadism Versus Pathological Hypogonadism
Pseudo-hypogonadism of obesity describes men whose total testosterone is low, LH and FSH are normal, and SHBG is reduced in proportion to their body weight. It's a functional state driven by adiposity that may improve or resolve with weight management. Pathological hypogonadism, by contrast, involves primary testicular failure (elevated LH/FSH) or a pituitary defect (low LH/FSH along with low testosterone). The clinical approach differs sharply: pseudo-hypogonadism typically responds to weight management, while pathological hypogonadism may warrant testosterone replacement therapy after clinical evaluation (Muir et al., 2025).
The Endocrine Society guideline recommends measuring free testosterone (by equilibrium dialysis or a reliable calculation) whenever SHBG is expected to be altered, as it is in obesity (Bhasin et al., 2018). Without that second marker, providers risk attributing symptoms to testosterone deficiency that are better explained by weight, sleep apnea, depression, or medications.
Which Labs Should You Order at a Higher Body Weight?
A standard testosterone panel usually reports total testosterone alone. For men with elevated BMI, that's not enough. Clinical guidelines from both the Endocrine Society and the AUA recommend adding free testosterone, SHBG, and gonadotropins (LH, FSH) to distinguish between functional and pathological causes of low readings (Bhasin et al., 2018; Mulhall et al., 2018).
A practical starting point is a testosterone lab panel that includes total testosterone (LC/MS), free testosterone (equilibrium dialysis), and SHBG. From the individual biomarkers catalog, an SHBG test can be added to any draw. Men also carrying metabolic risk factors (insulin resistance, elevated waist circumference, elevated HbA1c) may benefit from a broader lab bundle that captures a metabolic panel alongside the hormone markers.
The standard diagnostic protocol per AUA and Endocrine Society guidelines calls for two early-morning fasting draws, repeated 1-3 weeks apart using the same lab and assay. Timing and preparation make a measurable difference in results. A guide to testosterone test preparation covers what to do and avoid before a draw.
Does Losing Weight Raise Testosterone Levels?
The evidence supports this, and it's the first recommendation in current clinical guidelines for men whose low testosterone is associated with obesity.
A 2024 meta-analysis of 44 studies (1,774 participants, 2,159 data sets) found that weight loss increased total testosterone by a mean of 4.8 nmol/L. A low-calorie diet produced an increase of 2.5 nmol/L, while bariatric surgery produced 7.2 nmol/L. Free testosterone rose by 42.2 pmol/L across all methods. Larger gains occurred in men with higher baseline BMI or lower baseline SHBG and testosterone (Ken-Dror et al., 2024).
Preliminary data from a conference abstract presented at the Endocrine Society annual meeting in 2025 added a newer data point: among 110 men with obesity or type 2 diabetes treated with GLP-1 receptor agonists (not testosterone), the proportion with normal total and free testosterone rose from 53% to 77% after clinically meaningful weight reduction over 18 months (Portillo Canales et al., ENDO 2025). This is observational, not a randomized trial, but it supports the clinical pattern that weight loss alone can move testosterone readings back into the reference range for a sizable portion of men.
The AUA guideline recommends addressing weight and lifestyle before considering testosterone replacement for overweight men with low readings (Mulhall et al., 2018). That recommendation is grounded in the pseudo-hypogonadism framework: if SHBG and total testosterone are both low and LH/FSH are normal, the primary intervention is removing the reversible cause.
How Do Different Weight Loss Methods Affect Testosterone?
|
Method |
Total Testosterone Change |
Free Testosterone Change |
Evidence Level |
|
Low-calorie diet |
+2.5 nmol/L (mean) |
Increased (magnitude varies) |
Meta-analysis of pooled dietary trials (Ken-Dror et al., 2024) |
|
Bariatric surgery (RYGB, sleeve) |
+7.2 nmol/L (mean) |
+0.6% per kg lost over 36 months |
Meta-analysis + prospective cohort (Ken-Dror et al., 2024; Brzozowska et al., 2024) |
|
GLP-1 receptor agonists (semaglutide, tirzepatide) |
Normalization from 53% to 77% after weight reduction |
Improved in parallel |
Observational cohort, ENDO 2025 (Portillo Canales et al.) |
|
No intervention (untreated controls) |
No change or decline with continued weight gain |
Decline or no change |
Registry controls (Saad et al., 2020) |
The data above comes from different study designs, sample sizes, and follow-up periods. Larger weight loss produces larger testosterone recovery, regardless of method. The comparison table is informational, not a recommendation for one method over another. Any clinical decision about treatment should follow from lab results and provider evaluation.
Testosterone Therapy, Body Composition, and What the Evidence Shows
For men with confirmed pathological hypogonadism (not pseudo-hypogonadism of obesity), testosterone replacement therapy (TRT) is associated with changes in body composition: increased lean mass and reduced fat mass, based on controlled trial data reviewed in the Endocrine Society guideline (Bhasin et al., 2018). An 11-year registry of men with documented testosterone deficiency reported that treated men with obesity lost a clinically meaningful amount of weight over the follow-up period, while untreated controls gained weight (Saad et al., 2020). This is registry data, not a randomized trial, and the treated group received structured clinical monitoring for over a decade. Results vary by individual.
TRT is not indicated for weight loss, and it's not recommended for men whose low total testosterone is driven by obesity-related SHBG suppression with normal LH/FSH. The Endocrine Society and AUA are clear: address reversible causes first (Muir et al., 2025).
Clients interested in how their testing process works can review the ordering and draw process before scheduling labs.
TRAVERSE Trial: Cardiac Safety and Secondary Signals
The TRAVERSE trial (5,204 men with hypogonadism and cardiovascular risk) reported a neutral primary cardiovascular endpoint: major adverse cardiac events occurred in 7.0% of men on testosterone versus 7.3% on placebo (Lincoff et al., 2023). The FDA updated class-wide testosterone labeling in February 2025 based on these findings, removing the previous cardiovascular boxed warning and adding a blood-pressure warning.
Secondary signals from TRAVERSE require disclosure alongside the primary result. Atrial fibrillation was reported in 3.5% of the testosterone group versus 2.4% on placebo. Acute kidney injury occurred in 2.3% versus 1.5%. Pulmonary embolism occurred in approximately 0.9% versus 0.5%. A nested analysis of TRAVERSE also found no reduction in progression from prediabetes to diabetes with testosterone treatment compared to placebo.
When to Test and What to Expect
Any man carrying excess weight who wants to check his testosterone should include free testosterone and SHBG alongside total testosterone. A body weight testosterone test interpreted without SHBG can produce a misleadingly low result that doesn't reflect actual hormonal function.
The standard protocol calls for two early-morning fasting draws, confirmed on a repeated measurement 1-3 weeks later, using the same assay and lab. Reading a testosterone lab report is easier when both total and free values are on the page together with SHBG, because the three numbers tell a story that total testosterone alone doesn't.
If results confirm pathological hypogonadism (low testosterone with symptoms, after reversible causes are ruled out), a provider may evaluate whether treatment is appropriate. If results fit the pseudo-hypogonadism pattern (low total testosterone, low SHBG, normal LH/FSH), the evidence points toward weight management as the primary intervention, with follow-up labs to track recovery.
A body weight testosterone test reports where testosterone sits today. Paired with SHBG and gonadotropin values, it also answers why the number is where it is. That second piece of information is what a provider needs to recommend the right next step.
Disclaimer: This blog post is intended for informational purposes only and should not be considered medical advice. Always consult a healthcare professional before making changes to your health routine.
FAQs
Does body weight affect testosterone test results?
Yes. Higher body weight suppresses SHBG, the protein that binds and carries testosterone in the blood. When SHBG drops, measured total testosterone drops with it, even when free (usable) testosterone stays within the reference range. A 2025 clinical paper describes this pattern as pseudo-hypogonadism of obesity, a functional state distinct from pathological testosterone deficiency (Muir et al., 2025).
Should free testosterone be checked if BMI is elevated?
The Endocrine Society recommends measuring free testosterone whenever SHBG is expected to be low, as it is with obesity (Bhasin et al., 2018). Without free testosterone, a standard body weight testosterone test can produce a misleadingly low total value that doesn't reflect the amount of hormone available to tissues.
Can losing weight raise testosterone without medication?
A 2024 meta-analysis of 44 studies found that weight loss increased total testosterone by 4.8 nmol/L on average across dietary and surgical interventions, with larger gains in men who had higher starting BMI (Ken-Dror et al., 2024). Current AUA and Endocrine Society guidelines recommend weight management as the first-line approach for men whose low testosterone is associated with excess body weight.
Is low testosterone the cause of weight gain, or the result of it?
The relationship runs in both directions. Obesity suppresses the hormonal axis and lowers SHBG, producing low total testosterone readings. At the same time, low testosterone is associated with increased fat storage and reduced lean mass. Clinical guidelines treat obesity-related testosterone suppression as a reversible condition best addressed by weight management before any hormone therapy.
What did the TRAVERSE trial show about testosterone and weight?
A nested analysis of the TRAVERSE trial found no reduction in progression from prediabetes to diabetes with testosterone therapy compared to placebo. The primary cardiovascular endpoint was neutral, but secondary signals included higher rates of atrial fibrillation (3.5% versus 2.4%), acute kidney injury, and pulmonary embolism in the testosterone group (Lincoff et al., 2023).
Why is my total testosterone low if my LH and FSH are normal?
Normal LH and FSH with low total testosterone and low SHBG is a hallmark of pseudo-hypogonadism of obesity. The pituitary gland is functioning normally, but reduced SHBG from excess adiposity pulls total testosterone readings down. Free testosterone may still be within the reference range. This pattern is a clinical signal to address weight and metabolic health rather than start testosterone replacement (Muir et al., 2025).
How many testosterone tests are needed for a confirmed result?
Both the AUA and Endocrine Society recommend two separate early-morning fasting blood draws, repeated 1-3 weeks apart, using the same assay and laboratory. A single low reading does not confirm hypogonadism and can reflect normal daily variation, recent illness, or testing conditions (Bhasin et al., 2018).
Share:
Where Should I Get My Hormones Checked? Your Options
Finger Prick Vs Blood Draw For Hormone Test Accuracy